Cargando…
Glucocorticoids and prostate cancer treatment: friend or foe?
Glucocorticoids have been used in the treatment of prostate cancer to slow disease progression, improve pain control and offset side effects of chemo- and hormonal therapy. However, they may also have the potential to drive prostate cancer growth via mutated androgen receptors or glucocorticoid rece...
Autores principales: | Montgomery, Bruce, Cheng, Heather H, Drechsler, James, Mostaghel, Elahe A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023359/ https://www.ncbi.nlm.nih.gov/pubmed/24625881 http://dx.doi.org/10.4103/1008-682X.125392 |
Ejemplares similares
-
Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023) -
Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011) -
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia?
por: Rastrelli, Giulia, et al.
Publicado: (2019) -
Editorial: Glucocorticoid and bone: Friend or foe
por: Baschant, Ulrike, et al.
Publicado: (2022) -
The Human Microbiota and Prostate Cancer: Friend or Foe?
por: Massari, Francesco, et al.
Publicado: (2019)